Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Barry

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 21, 2016
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal AntibodiesDavid Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 21, 2016
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal AntibodiesDavid Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Pageof 5